Combined by former Zhejiang Xinchang Pharmaceutical Co.,Ltd., Zhejiang Xianju Pharmaceutical Co.,Ltd., and Zhejiang Medical and Pharmaceutical Co.,Ltd., Zhejiang Medicine Co.,Ltd (ZMC). was founded on May 16,1997,approved by China's Securities Supervision Commission,The corporation issued 58 million RMB ordinary shares in August,1999.In October,the corporation's shares went public in Shanghai Stock Market.As one of the largest 18 key group corporations in Zhejiang Province,Zhejiang Pharmaceutical's registered assets value 450.06 million yuan,and its total value reaches 2 billion yuan in present.

Zhejiang Medicine Co.,Ltd. (ZMC) consists of several enterprises and trading companies,such as Xinchang Pharmaceutical Factory,Vitamin Factory,Trading Company,Zhejiang Health Creation Bio-technology Co.,Ltd.,Shanghai Health Creation Bio-Pharmaceutical R&D Center.The corporation has more than 4000 employees,over 1600 of whom(above 40%)are technicians,and over 300 of whom are experts(above 8%).Zhejiang Medicine (ZMC) takes the "human-centered"credo and strives to make innovations in technology and management.It is a high-tech enterprise authenticated as the provincial technology center.It has a post-doctoratestation authorized by Mininstry of Personnel.
By the end of 2003,all of the corporation's products had passed national GMP authentication,and its trading company is among the first group of companies passing national GSP authentication.Meanwhile, the corporation attaches a vital importance to resource economy,environmental protection,and sustainable development.Laying stress on clean production and recycling system ,it passed ISO140001 Environmental.
Nowadays,Zhejiang Medicine (ZMC) has its professional and large-scale production of various kinds of vitamins and antibiotics,among which its vitamin H and Kitasamycin are the world's best in production and sales,and its coenzyme Q10 and vitamin E are the world's No:3.Zhejiang Medicine is a globally influential enterprise with large scale,solid finance,and advanced technology.
Zhejiang Medicine (ZMC) gives its top priority to "human health",and has set its 2010 goal,viz."three highs,tow lows,one combination"competition strategy.It aims to offer new products with hi-tech proportion,high market shares,high added value,low pollution,and low consumption.It also tries to create excellent brands for preparations and enlarge the scale for raw medicine.
With year's efforts and a solid base ,Zhejiang Medicine (ZMC) is at a full jump now,and the staff is striving to achieve the second great leap for the corporation.